NBP | NovaBridge Sp ADS | Owners

S&P 500$7,757.17
+0.58%
2m
DOW 30$52,856.09
+0.69%
2m
NASDAQ 100$29,822.52
+1.13%
2m
Russell 2000$276.48
+0.25%
2m
Russell 1000$422.30
+0.59%
2m
S&P 400$3,665.94
+0.40%
2m
S&P 600$1,675.64
+0.08%
2m

NovaBridge Sp ADS (NBP)

NASDAQ

$1.34-$0.04 (-2.55%)

Price as of Oct 22, 2026 7:30 PM EDT

$158.9M
Market Cap
N/A
1-Year Change
Biotechnology
Industry

Top Holders

Institutional

Mutual Funds

No data found

Holder	Ownership %	Shares Held	Change (Shares, %)	Report Date
SPDR INDEX SHARES FUNDS	0.72%	360,376	-9,731 (-2.70%)	Jun 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC	0.14%	70,801	-2,982 (-4.21%)	Jul 31, 2026
Blackstone Alternative Investment Funds	0.01%	5,100	+7,400 (+145.10%)	Jun 30, 2026
PROSHARES TRUST	0.008%	4,151	-650 (-15.66%)	May 31, 2026

Current Ownership Distribution

Mutual Funds69.1M (91.24%)
Insiders6.6M (8.76%)
Institutions0 (0.00%)
Other0 (0.00%)

Insider Transactions

8.76% (6.6M)
Current InsiderOwnership (%, shares)
0
Number of InsiderBuying (last 12 months)
$0.00
Amount of InsiderBuying (last 12 months)
3
Number of InsiderSelling (last 12 months)
$472,312.65
Amount of InsiderSelling (last 12 months)

Insider Name & Title	Type	Date	Transaction Value	Shares	Share Price	Shares After Transactions
Woo Ian Ying	Exempt	Oct 15, 2026	$0.00	5,770	$0.00	11,540
Woo Ian Ying	Exempt	Oct 15, 2026	$0.00	13,271	$0.00	13,271
Dennis Phillip Andrew Chief Medical Officer	Sell	Sep 18, 2026	$5,828.39	8,209	$0.71	173,427
Dennis Phillip Andrew Chief Medical Officer	Exempt	Sep 17, 2026	$0.00	10,302	$0.00	72,120
Dennis Phillip Andrew Chief Medical Officer	Exempt	Sep 17, 2026	$0.00	23,695	$0.00	181,636
Cao Sean Wuxiong Chief Bus. Development Officer	Sell	Sep 09, 2026	$79,903.72	107,978	$0.74	266,467
Cao Sean Wuxiong Chief Bus. Development Officer	Exempt	Sep 03, 2026	$0.00	102,233	$0.00	306,700
Cao Sean Wuxiong Chief Bus. Development Officer	Exempt	Sep 03, 2026	$0.00	45,320	$0.00	135,960
Cao Sean Wuxiong Chief Bus. Development Officer	Exempt	Sep 03, 2026	$0.00	235,136	$0.00	270,209
Cao Sean Wuxiong Chief Bus. Development Officer	Exempt	Sep 03, 2026	$0.00	104,236	$0.00	374,445
Xu Cong Claire EVP, Clinical Development	Sell	Aug 31, 2026	$2,592.78	3,282	$0.79	304,201
Xu Cong Claire EVP, Clinical Development	Exempt	Aug 30, 2026	$0.00	4,079	$0.00	28,558
Xu Cong Claire EVP, Clinical Development	Exempt	Aug 30, 2026	$0.00	9,382	$0.00	307,483
Lenz Robert A.	Exempt	Aug 22, 2026	$0.00	7,486	$0.00	14,974
Lenz Robert A.	Exempt	Aug 22, 2026	$0.00	17,218	$0.00	17,218
Hagler Mark Arnold Chief Commercial Officer	Award	Jul 08, 2026	$0.00	949,050	$0.00	949,050
Gupta Srishti Chief Executive Officer	Award	Jul 06, 2026	$0.00	3.0M	$0.00	3.0M
Fu Wei	Award	Jun 29, 2026	$0.00	725,140	$0.00	725,140
Fu Wei	Award	Jun 29, 2026	$0.00	1.1M	$0.00	1.1M
Fu Wei	Award	Jun 29, 2026	$0.00	1.1M	$0.00	1.1M
Fu Wei	Award	Jun 29, 2026	$0.00	1.0M	$0.00	1.0M